Related Experiment Videos
[Pneumatosis cystoides intestinalis in systemic diseases: 3 cases]
A Grasland1, J Pouchot, J Leport
1Service de Médecine interne, Hôpital Louis Mourier, Colombes.
Summary
Pneumatosis cystoides intestinalis (PCI) can occur in systemic diseases, particularly systemic sclerosis. Corticosteroid therapy and digestive tract vasculitis are key factors, with medical treatment generally leading to favorable outcomes for this rare condition.
Area of Science:
- Gastroenterology
- Rheumatology
- Internal Medicine
Background:
- Pneumatosis cystoides intestinalis (PCI) is a rare condition characterized by gas-filled cysts in the intestinal wall.
- While often linked to gastrointestinal or respiratory issues, PCI can also manifest as a complication of systemic diseases, most commonly systemic sclerosis.
- This abstract explores the association between PCI and various systemic autoimmune and inflammatory conditions.
Observation:
- Three patients with systemic vasculitis (temporal arteritis, polyarteritis nodosa) treated with prednisone developed PCI.
- One patient experienced a complication of retropneumoperitoneum.
- All patients achieved a favorable outcome with medical management.
Findings:
- A review of 62 reported cases reveals systemic sclerosis as the most frequent associated condition (45%).
- Other implicated systemic diseases include systemic lupus erythematosus, mixed connective tissue disease, dermatopolymyositis, polyarteritis nodosa, rheumatoid arthritis, Sjögren's syndrome, and amyloidosis.
- Corticosteroid therapy and digestive tract vasculitis are identified as primary causal factors in non-scleroderma cases.
Implications:
- PCI associated with systemic diseases, particularly those treated with corticosteroids, requires careful monitoring.
- Medical management, including corticosteroids, appears effective in treating PCI in these patient populations.
- Surgical intervention is rarely necessary, emphasizing the importance of conservative treatment strategies for this condition.